C08.1
C08.1 — Malignant neoplasm of sublingual gland
Billable / specific codeICD-10-CM
C08.1 is a billable, specific ICD-10-CM code for malignant neoplasm of sublingual gland. It is valid for submission on a claim.
Risk adjustment
C08.1 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 21 Lymphoma and Other Cancers0.671 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C08.1 is named in 65 Medicare coverage policies — 65 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52453Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
Related codes at this level
Codes that share C08. If C08.1 is not quite right, the correct code is usually one of these.
Questions about C08.1
- Is C08.1 a billable ICD-10-CM code?
- Yes. C08.1 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C08.1 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of lip, oral cavity and pharynx (C00-C14).